-
Biomarkers for antigen immunotherapy in allergy and type 1 diabetes.
Clin ImmunolOdegard JM, Nepom GT, Wambre E -
Hematopoietic and nonhematopoietic cells promote Type I interferon- and TLR7-dependent monocytosis during low-dose LCMV infection.
Eur J ImmunolBuechler MB, Gessay GM, Srivastava S, Campbell DJ, Hamerman JA -
De-Mst-ifying microbicidal killing.
Nature ImmunologyStuart LM, Lacy-Hulbert A -
T cell epitopes and post-translationally modified epitopes in type 1 diabetes.
Curr Diab RepMcGinty JW, Marré ML, Bajzik V, Piganelli JD, James EA -
Promises and paradoxes of regulatory T cells in inflammatory bowel disease.
World J GastroenterolLord JD -
β cell ER stress and the implications for immunogenicity in type 1 diabetes.
Frontiers in Cell and Developmental BiologyMarré ML, James EA, Piganelli JD -
The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells
ImmunityRay JP, Staron MM, Shyer JA, Ho PC, Marshall HD, Gray SM, Laidlaw BJ, Araki K, Ahmed R, Kaech SM, Craft J -
Microbiota-Dependent Sequelae of Acute Infection Compromise Tissue-Specific Immunity
CellMorais de Fonseca D, Hand TW, Seong-Ji H, Gerner MY, Zaretsky AG, Byrd AL, Harrison OJ, Ortiz AM, Quinones M, Trinchieri G, Brenchley JM, Brodsky IE, Germain RN, Randolph GJ, Belkaid Y -
Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I
mBioXu J, Mercado-López X, Grier JT, Kim WK, Chun LF, Irvine EB, Del Toro Duany Y, Kell A, Hur S, Gale M Jr, Raj A, López CB -
Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy.
J Allergy Clin ImmunolArchila LD, Jeong D, Pascal M, Bartra J, Juan M, Robinson D, Farrington ML, Kwok WW -
Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis.
The Journal of Clinical InvestigationNagy N, Kaber G, Johnson PY, Gebe JA, Preisinger A, Falk BA, Sunkari VG, Gooden MD, Vernon RB, Bogdani M, Kuipers HF, Day AJ, Campbell DJ, Wight TN, Bollyky PL -
Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.
Diabetes CareWherrett DK, Chiang JL, Delamater AM, DiMeglio LA, Gitelman SE, Gottlieb PA, Herold KC, Lovell DJ, Orchard TJ, Ryan CM, Schatz DA, Wendler DS, Greenbaum CJ, Type 1 Diabetes TrialNet Study Group. -
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.
Diabetes CareInsel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, Greenbaum CJ, Herold KC, Krischer JP, Lernmark A, Ratner RE, Rewers MJ, Schatz DA, Skyler JS, Sosenko JM, Ziegler AG -
The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types.
PLoS OneLinsley PS, Chaussabel D, Speake C -
Control of Regulatory T Cell Migration, Function, and Homeostasis.
Journal of ImmunologyCampbell DJ
